MedAssets (NASDAQ:MDAS) Stock Price, News, Analysis & History

Previous CloseN/A
Today's RangeN/A
52-Week RangeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E Ratio-53.14
Dividend YieldN/A

About MedAssets (NASDAQ:MDAS)

MedAssets logoMedAssets, Inc. (MedAssets) provides technology-enabled products and services to healthcare organizations, including hospitals, health systems, non-acute healthcare providers, payers, other service providers and product manufacturers. The Company operates its business through two business segments: Spend and Clinical Resource Management (SCM) and Revenue Cycle Management (RCM). The SCM segment delivers market insight, performance improvement advisory and cost management capabilities to healthcare providers. The RCM segment provides revenue cycle management solutions to healthcare providers, primarily hospitals and health systems. The Company's technology-enabled solutions are delivered through the Company-hosted software or software as a service (SaaS) or Web-based applications. Its Web-based applications employ cloud computing by using the Internet to deploy the Company's solutions across decentralized health care organizations, providing standardization and compliance.

Receive MDAS News and Ratings via Email

Sign-up to receive the latest news and ratings for MDAS and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry IT Services & Consulting
Sub-IndustryHealth Care Technology


Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A


Trailing P/E Ratio-53.135593220339
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A


Trailing EPS($0.59)
Net IncomeN/A
Net Margins-1.18%
Return on Equity-2.00%
Return on Assets-0.54%


Outstanding SharesN/A

MedAssets (NASDAQ:MDAS) Frequently Asked Questions

What is MedAssets' stock symbol?

MedAssets trades on the NASDAQ under the ticker symbol "MDAS."

How were MedAssets' earnings last quarter?

MedAssets, Inc. (NASDAQ:MDAS) posted its quarterly earnings results on Wednesday, July, 29th. The technology company reported $0.31 earnings per share for the quarter, topping analysts' consensus estimates of $0.27 by $0.04. The technology company had revenue of $190.40 million for the quarter, compared to analyst estimates of $187.45 million. MedAssets had a negative net margin of 1.18% and a negative return on equity of 2.00%. MedAssets's quarterly revenue was up 8.6% on a year-over-year basis. During the same period in the previous year, the business posted $0.30 earnings per share. View MedAssets' Earnings History.

Who are some of MedAssets' key competitors?

Has MedAssets been receiving favorable news coverage?

Press coverage about MDAS stock has trended somewhat positive recently, according to Accern. The research firm identifies positive and negative news coverage by reviewing more than twenty million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. MedAssets earned a news impact score of 0.06 on Accern's scale. They also gave media stories about the technology company an impact score of 45.94 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the stock's share price in the near future.

How do I buy shares of MedAssets?

Shares of MDAS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How can I contact MedAssets?

MedAssets' mailing address is 100 N Point Ctr E Ste 200, ALPHARETTA, GA 30022-8261, United States. The technology company can be reached via phone at +1-678-3232500.

MarketBeat Community Rating for MedAssets (MDAS)

Community Ranking:  2.1 out of 5 (star star)
Outperform Votes:  214 (Vote Outperform)
Underperform Votes:  303 (Vote Underperform)
Total Votes:  517
MarketBeat's community ratings are surveys of what our community members think about MedAssets and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

MedAssets (NASDAQ:MDAS) Analyst Ratings History

No equities research coverage for this company has been tracked by MarketBeat


MedAssets (NASDAQ:MDAS) Earnings History and Estimates Chart

Earnings by Quarter for MedAssets (NASDAQ:MDAS)

MedAssets (NASDAQ MDAS) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/2/2015Q315$0.28$0.27$187.34 million$117.20 millionViewN/AView Earnings Details
7/29/2015Q2$0.27$0.31$187.45 million$190.40 millionViewListenView Earnings Details
4/29/2015Q115$0.30$0.31$184.33 million$185.58 millionViewN/AView Earnings Details
2/17/2015Q414$0.39$0.39$195.00 million$198.20 millionViewN/AView Earnings Details
10/29/2014Q314$0.31$0.34$172.50 million$175.70 millionViewListenView Earnings Details
7/30/2014Q214$0.29$0.30$175.70 million$175.42 millionViewListenView Earnings Details
4/30/2014Q114$0.29$0.27$172.30 million$170.87 millionViewListenView Earnings Details
2/26/2014Q413$0.28$0.30$165.64 million$170.50 millionViewListenView Earnings Details
10/30/2013Q3 2013$0.26$0.27$166.94 million$166.37 millionViewN/AView Earnings Details
7/31/2013Q2 2013$0.26$0.30$167.64 million$170.70 millionViewN/AView Earnings Details
5/1/2013Q1 2013$0.30$0.41$164.75 million$172.84 millionViewN/AView Earnings Details
2/20/2013Q4 2012$0.28$0.27$159.84 million$163.80 millionViewN/AView Earnings Details
10/30/2012$0.26$0.32ViewN/AView Earnings Details
8/1/2012$0.22$0.28ViewN/AView Earnings Details
5/2/2012$0.18$0.24ViewN/AView Earnings Details
2/23/2012$0.32$0.32ViewN/AView Earnings Details
11/3/2011$0.16$0.26ViewN/AView Earnings Details
8/1/2011$0.16$0.23ViewN/AView Earnings Details
5/5/2011$0.16$0.17ViewN/AView Earnings Details
2/24/2011$0.22$0.18ViewN/AView Earnings Details
10/27/2010Q3 2010$0.21$0.23ViewN/AView Earnings Details
8/4/2010Q2 2010$0.13$0.14ViewN/AView Earnings Details
4/29/2010Q1 2010$0.14$0.16ViewN/AView Earnings Details
2/22/2010Q4 2009$0.23$0.24ViewN/AView Earnings Details
10/28/2009Q3 2009$0.15$0.18ViewN/AView Earnings Details
8/3/2009Q2 2009$0.11$0.12ViewN/AView Earnings Details
4/29/2009Q1 2009$0.11$0.11ViewN/AView Earnings Details
2/25/2009Q4 2008$0.16$0.19ViewN/AView Earnings Details
11/13/2008Q3 2008$0.13$0.14ViewN/AView Earnings Details
8/13/2008Q2 2008$0.11$0.11ViewN/AView Earnings Details
5/14/2008Q1 2008$0.10$0.11ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)


MedAssets (NASDAQ:MDAS) Earnings Estimates

No earnings estimates for this company have been tracked by


Dividend History for MedAssets (NASDAQ:MDAS)

No dividend announcements for this company have been tracked by

Insider Trades

MedAssets (NASDAQ MDAS) Insider Trading and Institutional Ownership History

Insider Trades by Quarter for MedAssets (NASDAQ:MDAS)
Institutional Ownership by Quarter for MedAssets (NASDAQ:MDAS)

MedAssets (NASDAQ MDAS) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/26/2015John A BardisDirectorSell2,000$19.73$39,460.00View SEC Filing  
2/24/2015John A BardisDirectorSell100,000$19.45$1,945,000.00View SEC Filing  
2/19/2015R Halsey WiseCEOBuy110,300$18.15$2,001,945.00View SEC Filing  
11/26/2014Keith L ThurgoodInsiderSell5,681$19.54$111,006.74View SEC Filing  
11/12/2014Harris Iv HymanDirectorSell3,334$20.50$68,347.00View SEC Filing  
11/11/2014John A BardisCEOSell100,000$20.02$2,002,000.00View SEC Filing  
11/7/2014John A BardisCEOSell191,833$20.74$3,978,616.42View SEC Filing  
11/4/2014John A BardisCEOSell208,167$21.48$4,471,427.16View SEC Filing  
10/28/2014Jonathan H GlennInsiderSell7,300$22.62$165,126.00View SEC Filing  
10/27/2014Jonathan H GlennInsiderSell500$22.50$11,250.00View SEC Filing  
8/13/2014Terrence J MulliganDirectorSell1,000$21.97$21,970.00View SEC Filing  
7/10/2014Terrence J MulliganDirectorSell1,000$21.97$21,970.00View SEC Filing  
7/1/2014Charles O GarnerCFOSell3,167$22.81$72,239.27View SEC Filing  
6/12/2014Terrence J MulliganDirectorSell1,000$23.30$23,300.00View SEC Filing  
5/14/2014Terrence MulliganDirectorSell1,000$22.93$22,930.00927View SEC Filing  
5/2/2014R Halsey WiseDirectorBuy8,950$22.31$199,674.508,950View SEC Filing  
4/10/2014Terrence MulliganDirectorSell1,000$24.56$24,560.00927View SEC Filing  
3/13/2014Terrence MulliganDirectorSell1,000$25.24$25,240.00927View SEC Filing  
2/28/2014Charles GarnerCFOSell8,949$24.05$215,223.4572,000View SEC Filing  
2/24/2014Terrence MulliganDirectorSell1,000$21.97$21,970.00View SEC Filing  
1/16/2014Charles GarnerCFOSell15,207$20.83$316,761.817,849View SEC Filing  
1/16/2014Terrence MulliganDirectorSell2,000$21.97$43,940.00View SEC Filing  
11/26/2013John RutherfordDirectorSell13,000$21.41$278,330.005,944View SEC Filing  
11/21/2013Bruce WessonDirectorSell60,263$20.54$1,237,802.025,168View SEC Filing  
11/15/2013Terrence MulliganDirectorSell1,000$21.97$21,970.00776View SEC Filing  
11/8/2013John BardisCEOSell200,000$22.04$4,408,000.0020,995View SEC Filing  
10/22/2013Lance M CulbrethCAOSell2,000$26.45$52,900.00View SEC Filing  
10/8/2013Terrence MulliganDirectorSell1,000$24.64$24,640.00776View SEC Filing  
9/17/2013Terrence MulliganDirectorSell1,000$24.21$24,210.00776View SEC Filing  
9/11/2013Lance M CulbrethCAOSell4,000$24.23$96,920.00View SEC Filing  
9/10/2013Jonathan H GlennInsiderSell12,268$24.00$294,432.00View SEC Filing  
8/29/2013Charles GarnerCFOSell2,017$23.02$46,431.347,849View SEC Filing  
8/29/2013Harris Iv HymanDirectorSell3,199$23.26$74,408.744,652View SEC Filing  
8/26/2013Harris Iv HymanDirectorSell5,985$23.50$140,647.504,652View SEC Filing  
8/23/2013C PiccoloDirectorSell17,487$22.94$401,151.787,236View SEC Filing  
8/23/2013John BardisCEOSell17,304$23.04$398,684.1620,995View SEC Filing  
8/15/2013John BardisCEOSell10,000$22.87$228,700.0020,995View SEC Filing  
8/14/2013Terrence MulliganDirectorSell5,000$23.50$117,500.00776View SEC Filing  
8/9/2013John RutherfordDirectorSell50,000$23.62$1,181,000.005,944View SEC Filing  
8/5/2013Lance M CulbrethCAOSell22,866$23.34$533,692.44View SEC Filing  
8/2/2013Gregory StrobelInsiderSell4,025$22.78$91,689.5011,871View SEC Filing  
8/2/2013Terrence MulliganDirectorSell29,446$23.39$688,741.94776View SEC Filing  
7/23/2013Michael Patrick NolteCOOSell20,000$21.04$420,800.00View SEC Filing  
7/17/2013Lance M CulbrethCAOSell4,500$20.45$92,025.00View SEC Filing  
7/16/2013Michael Patrick NolteCOOSell19,222$19.63$377,327.86View SEC Filing  
7/16/2013Rand A BallardInsiderSell13,163$20.00$263,260.00View SEC Filing  
7/16/2013Terrence J MulliganDirectorSell55,000$20.00$1,100,000.00View SEC Filing  
5/10/2013Lance M CulbrethCAOSell16,000$18.54$296,640.00View SEC Filing  
3/25/2013Charles O GarnerCFOSell15,038$19.38$291,436.44View SEC Filing  
11/27/2012Gregory A StrobelInsiderSell10,000$16.24$162,400.00View SEC Filing  
11/27/2012John A BardisCEOSell107,550$16.51$1,775,650.50View SEC Filing  
11/14/2012John A BardisCEOSell71,340$16.34$1,165,695.60View SEC Filing  
(Data available from 1/1/2013 forward)


MedAssets (NASDAQ MDAS) News Headlines


SEC Filings

MedAssets (NASDAQ:MDAS) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media


MedAssets (NASDAQ:MDAS) Income Statement, Balance Sheet and Cash Flow Statement


MedAssets (NASDAQ MDAS) Stock Chart for Thursday, March, 22, 2018

Loading chart…

This page was last updated on 3/22/2018 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.